A different approach to telomere analysis with ddPRINS in chronic lymphocytic leukemia

被引:1
作者
Palanduz, S [1 ]
Serakinci, N
Cefle, K
Aktan, M
Tutkan, G
Ozturk, S
Bozkurt, G
Dincol, G
Pekcelen, Y
Koch, J
机构
[1] Istanbul Univ, Dept Internal Med, Istanbul Fac Med, Div Med Genet, Istanbul, Turkey
[2] Danish Canc Soc, Dept Cytogenet, DK-8000 Aarhus, Denmark
[3] Istanbul Univ, Dept Internal Med, Istanbul Fac Med, Div Haematol, Istanbul, Turkey
[4] Trakya Univ, Dept Med Biol, Trakya Med Fac, Trakya, Turkey
关键词
chronic lymphocytic leukemia; telomere;
D O I
10.1016/j.ejmg.2005.01.023
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Telomeric sequences, located at the very end of the chromosomes, compensate for the chromosomal shortening as it happens after each round of cell division. Telomeric sequences influence the progress of cellular senescence and cancer progression. It has been reported that telomeres are shortened in acute leukemias where the cell turnover is high. B-cell chronic lymphocytic leukemia (CLL) is a particularly interesting haematological malignancy in regard to telomere dynamics because most of the malignant cells in CLL are mitotically inactive. In this study, we analysed the telomere length in patients with B-cell CLL in a comparison with the control group by using ddPRINS technique. Twenty patients with CLL and four healthy donors as a control group were included. We found short telomeres and no detectable telomeric repeats at the sites of chromosome fusion. We hypothesise that the telomeric erosion in CLL may reflect the dominance of malignant cells with an abnormally long life span. These cells may have encountered many antigenic stimulants in the past and hence underwent multiple clonal expansions. Our findings imply that shortened telomeres in CLL may be reflecting the "history" of the disease and serve as an independent prognostic factor. (c) 2004 Published by Elsevier SAS.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 50 条
  • [31] Obinutuzumab in chronic lymphocytic leukemia
    Dupuis, Jehan
    FUTURE ONCOLOGY, 2015, 11 (18) : 2503 - 2513
  • [32] Autoimmunity in chronic lymphocytic leukemia
    Ward J.H.
    Current Treatment Options in Oncology, 2001, 2 (3) : 253 - 257
  • [33] Immunogenetics of chronic lymphocytic leukemia
    Patkar, Nikhil
    Rabade, Nikhil
    Kadam, Pratibha Amare
    Mishra, Falguni
    Muranjan, Aditi
    Tembhare, Prashant
    Chaudhary, Shruti
    Joshi, Swapnali
    Jain, Hasmukh
    Dangi, Uma
    Bagal, Bhausaheb
    Khattry, Navin
    Menon, Hari
    Gujral, Sumeet
    Sengar, Manju
    Subramanian, P. G.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2017, 60 (01) : 38 - 42
  • [34] Acalabrutinib in chronic lymphocytic leukemia
    Martino, Enrica Antonia
    Bruzzese, Antonella
    Vigna, Ernesto
    Iaccino, Enrico
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Filippelli, Gianfranco
    Neri, Antonino
    Morabito, Fortunato
    Gentile, Massimo
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (05) : 545 - 549
  • [35] Chronic lymphocytic leukemia.
    Andritsos L.
    Khoury H.
    Current Treatment Options in Oncology, 2002, 3 (3) : 225 - 231
  • [36] CHRONIC LYMPHOCYTIC-LEUKEMIA
    CAGUIOA, PB
    TANSAN, S
    MCCAFFREY, RP
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1994, 308 (03) : 196 - 200
  • [37] CHRONIC LYMPHOCYTIC-LEUKEMIA
    HINTERBERGER, W
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1991, 141 (9-10) : 198 - 201
  • [38] MicroRNAs in chronic lymphocytic leukemia
    Ward, Brian P.
    Tsongalis, Gregory J.
    Kaur, Prabhjot
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2011, 90 (02) : 173 - 178
  • [39] Immunotherapy in chronic lymphocytic leukemia
    Øystein Bruserud
    Emmet McCormack
    Bjørn Tore Gjertsen
    Cancer Immunology, Immunotherapy, 2006, 55 (2) : 185 - 187
  • [40] Chronic lymphocytic leukemia in pregnancy
    Chrisomalis, L
    Baxi, LV
    Heller, D
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (05) : 1381 - 1382